[go: up one dir, main page]

HRP20140660T4 - Pripravci i njihove upotrebe - Google Patents

Pripravci i njihove upotrebe Download PDF

Info

Publication number
HRP20140660T4
HRP20140660T4 HRP20140660TT HRP20140660T HRP20140660T4 HR P20140660 T4 HRP20140660 T4 HR P20140660T4 HR P20140660T T HRP20140660T T HR P20140660TT HR P20140660 T HRP20140660 T HR P20140660T HR P20140660 T4 HRP20140660 T4 HR P20140660T4
Authority
HR
Croatia
Prior art keywords
starch
semicrystalline
individual
use according
hypoglycemia
Prior art date
Application number
HRP20140660TT
Other languages
English (en)
Inventor
Xin Qi
Richard Tester
Original Assignee
Glycologic Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29726075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20140660(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glycologic Limited filed Critical Glycologic Limited
Publication of HRP20140660T1 publication Critical patent/HRP20140660T1/hr
Publication of HRP20140660T4 publication Critical patent/HRP20140660T4/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Claims (6)

1. Upotreba škroba u pripremi terapeutskog prehrambenog pripravka ili terapeutske hrane za liječenje ili prevenciju hipoglikemije u pojedincu, pri čemu je spomenuti škrob semikristalični voštani kukuruzni škrob tretiran toplinom i vlagom.
2. Upotreba prema zahtjevu 1 pri čemu spomenuti pojedinac ima bolest pohrane glikogena.
3. Upotreba prema zahtjevu 1 pri čemu spomenuti pojedinac ima dijabetes Tipa I ili Tipa II.
4. Upotreba prema zahtjevu 1 pri čemu spomenuti pojedinac ima bolest jetre povezanu sa prisustvom ili podložnosti hipoglikemiji.
5. Upotreba prema bilo kojem od zahtjeva 1 do 4 pri čemu prehrambeni škrob tretiran toplinom i vlagom jest semikristalični škrob i semikristalični škrob ima sadržaj amilopektina od barem 70%.
6. Upotreba prema bilo kojem od zahtjeva 1 do 47 pri čemu semikristalični škrob ima sadržaj amilopektina od barem 80%.
HRP20140660TT 2003-11-06 2004-11-08 Pripravci i njihove upotrebe HRP20140660T4 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0325942.1A GB0325942D0 (en) 2003-11-06 2003-11-06 Compositions and uses thereof
EP04798407.5A EP1680134B2 (en) 2003-11-06 2004-11-08 Compositions and uses therof
PCT/GB2004/004682 WO2005044284A1 (en) 2003-11-06 2004-11-08 Compositions and uses therof

Publications (2)

Publication Number Publication Date
HRP20140660T1 HRP20140660T1 (en) 2014-10-10
HRP20140660T4 true HRP20140660T4 (hr) 2018-08-10

Family

ID=29726075

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140660TT HRP20140660T4 (hr) 2003-11-06 2004-11-08 Pripravci i njihove upotrebe

Country Status (16)

Country Link
US (1) US8507462B2 (hr)
EP (1) EP1680134B2 (hr)
JP (1) JP5248776B2 (hr)
CN (1) CN1901922B (hr)
AU (1) AU2004287263B2 (hr)
CA (1) CA2544965C (hr)
CY (1) CY1115306T1 (hr)
DK (1) DK1680134T4 (hr)
ES (1) ES2478565T5 (hr)
GB (1) GB0325942D0 (hr)
HR (1) HRP20140660T4 (hr)
NZ (1) NZ546987A (hr)
PL (1) PL1680134T5 (hr)
PT (1) PT1680134E (hr)
SI (1) SI1680134T2 (hr)
WO (1) WO2005044284A1 (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325942D0 (en) † 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
US8557274B2 (en) 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
WO2010077635A2 (en) * 2008-12-09 2010-07-08 The Ucan Company Heat moisture treated carbohydrates and uses thereof
US9481777B2 (en) 2012-03-30 2016-11-01 The Procter & Gamble Company Method of dewatering in a continuous high internal phase emulsion foam forming process

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1306384A (hr) * 1969-05-05 1973-02-07
GB2026837A (en) * 1978-07-31 1980-02-13 Cpc International Inc Starch containing food products
WO1990015147A1 (en) † 1989-06-06 1990-12-13 Washington State University Research Foundation, Inc. Purified resistant starch products and their preparation
JP2996707B2 (ja) * 1990-09-21 2000-01-11 三和興産株式会社 湿熱処理澱粉の効率的製造法
JPH06169680A (ja) * 1992-12-09 1994-06-21 Sanwa Kosan Kk パン類およびパン粉の製造法
US5843921A (en) † 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
IL112967A0 (en) † 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
US5576048A (en) * 1995-06-07 1996-11-19 American Maize-Products Company Foodstuffs containing a waxy waxy amylose extender starch
JP2790610B2 (ja) * 1994-07-21 1998-08-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤、それを含む糖組成物、甘味料、食品、及び飼料
JPH09172961A (ja) * 1995-12-22 1997-07-08 Oyama Nyugyo Nogyo Kyodo Kumiai ファットスプレッド様の発酵乳
JPH11130696A (ja) * 1997-08-27 1999-05-18 Takeda Chem Ind Ltd 経口徐放性製剤
US6238708B1 (en) * 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
DE19911001C2 (de) * 1999-03-12 2002-06-20 Aventis Cropscience Gmbh Verfahren zur Herstellung resistenter Stärke, resistente Stärke und deren Verwendung
FR2791686A1 (fr) * 1999-03-30 2000-10-06 Ulice Produits issus d'un ble a tres haute teneur en amylopectine et ses applications.
US6733815B2 (en) * 1999-04-16 2004-05-11 Cargill, Incorporated Food ingredient containing wheat gluten, soy grits and soy flour
JP3113873B1 (ja) * 1999-11-09 2000-12-04 株式会社日麺 ゆで麺及びその製造法
AUPQ673300A0 (en) * 2000-04-06 2000-05-04 Penford Australia Limited Starch sub-types and lipid metabolism
WO2002034271A1 (en) * 2000-10-25 2002-05-02 Metcon Medicin Ab New composition and method for the treatment of dysglucaemia
US6890571B2 (en) † 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US7081261B2 (en) † 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
GB0325942D0 (en) † 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
US20060025381A1 (en) † 2004-07-29 2006-02-02 National Starch And Chemical Investment Holding Company Use of a chemically modified starch product

Also Published As

Publication number Publication date
US20070077277A1 (en) 2007-04-05
JP2007510704A (ja) 2007-04-26
CN1901922A (zh) 2007-01-24
PL1680134T3 (pl) 2014-10-31
GB0325942D0 (en) 2003-12-10
SI1680134T1 (sl) 2014-09-30
HK1097754A1 (en) 2007-07-06
CN1901922B (zh) 2011-10-26
CA2544965A1 (en) 2005-05-19
HRP20140660T1 (en) 2014-10-10
JP5248776B2 (ja) 2013-07-31
ES2478565T5 (es) 2018-04-17
CY1115306T1 (el) 2017-01-04
DK1680134T3 (da) 2014-07-14
ES2478565T3 (es) 2014-07-22
EP1680134B1 (en) 2014-04-30
NZ546987A (en) 2009-09-25
EP1680134B2 (en) 2018-03-07
PL1680134T5 (pl) 2018-06-29
AU2004287263B2 (en) 2011-01-27
US8507462B2 (en) 2013-08-13
WO2005044284A1 (en) 2005-05-19
EP1680134A1 (en) 2006-07-19
CA2544965C (en) 2013-10-29
AU2004287263A1 (en) 2005-05-19
PT1680134E (pt) 2014-07-16
SI1680134T2 (en) 2018-04-30
DK1680134T4 (en) 2018-04-23

Similar Documents

Publication Publication Date Title
Rennard et al. Chicken soup inhibits neutrophil chemotaxis in vitro
ATE363896T1 (de) Gegen missbrauch gesicherte darreichungsform
BRPI0503981A (pt) substituto do açúcar apetecìvel, de baixa caloria com agente de volume insolúvel em água
ATE415947T1 (de) Verwendung von stärke mit abgespaltenen seitenketten in der extrudierung / spheronisierung von pharmazeutischen pellets
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
HRP20140660T4 (hr) Pripravci i njihove upotrebe
ATE397453T1 (de) Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
Thornton Coerced Care: Thomas Thistlewood's Account of Medical Practice on Enslaved Populations in Colonial Jamaica, 1751–1786
PL2193789T3 (pl) Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji
EP1797887A4 (en) MEDICAMENT FOR REDUCING THE INFLAMMATION OF NEUTRAL FAT IN THE BLOOD AFTER A MEAL AND THE FOOD CONTAINING THEREOF
Nowakowska et al. Anxiolytic and memory improving effects of moclobemide
WO2001059155A3 (en) Interferon-alpha induced genes
Yoo et al. A Study on the inhibitory function among foods and herb drugs
Higashiura et al. Magnesium and insulin resistance
Ahola Effects of social and physical housing environment on the welfare in silver foxes (Vulpes vulpes)
Chatterjee Perforator flaps
Westerfield For Jax
Graul The year's new drugs
Goldsmith et al. Use of subtherapeutic antibiotics in livestock (as supplements or feed additives) with the induction of resistance in human bacterial pathogens, the magnitude and complexity of the problem become increasingly clear
JP2777046B2 (ja) 寿 司
RU2002112883A (ru) Способ повышения продуктивности и резистентности новотельных коров
Clarke et al. Happy eaters; Blossoming with joy
ITTO981037A0 (it) Composizione farmaceutica, in particolare di tipo dietetico ad azione metabolica e termogenica utilizzabile nel trattamento del sovrappeso
Koenig et al. ScienceScope
Jain et al. Role of Shatyadi yoga in the management of Tamak shwasa (Bronchial Asthma)